Global Prostate Cancer Medicine Market Size, Status and Forecast 2021-2027

前立腺がん治療の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Prostate Cancer Medicine Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2772
◆調査・発行会社:QYResearch
◆発行日:2021年6月
◆ページ数:106
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥448,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥672,750見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、前立腺がん治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(LHRH拮抗薬、LHRHアナログ、抗アンドロゲン、ホルモン療法用パイプライン薬)、用途別市場規模(病院、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・前立腺がん治療の市場動向
・企業の競争状況、市場シェア
・前立腺がん治療の種類別市場規模(LHRH拮抗薬、LHRHアナログ、抗アンドロゲン、ホルモン療法用パイプライン薬)
・前立腺がん治療の用途別市場規模(病院、その他)
・前立腺がん治療の北米市場規模2016-2027(アメリカ、カナダ)
・前立腺がん治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・前立腺がん治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・前立腺がん治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・前立腺がん治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(AstraZeneca plc、Active Biotech、Bristol Myers-Squibb、Teva Pharmaceuticals Industries Ltd.、Johnson & Johnson、Pfizer Inc.、Bayer AG、Abbott Laboratories、Astellas Pharma Inc.、Roche Holding AG)
・結論

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise, ethnicity (African American men), and old age contribute to its occurrence.

Market Analysis and Insights: Global Prostate Cancer Medicine Market
The global Prostate Cancer Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Cancer Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Cancer Medicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Cancer Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Cancer Medicine market.

Global Prostate Cancer Medicine Scope and Market Size
Prostate Cancer Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
LHRH Antagonists
LHRH Analogs
Antiandrogens
Pipeline Drugs for Hormonal Therapy

Segment by Application
Hospitals
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca plc
Active Biotech
Bristol Myers-Squibb
Teva Pharmaceuticals Industries Ltd.
Johnson & Johnson
Pfizer Inc.
Bayer AG
Abbott Laboratories
Astellas Pharma Inc.
Roche Holding AG

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 LHRH Antagonists
1.2.3 LHRH Analogs
1.2.4 Antiandrogens
1.2.5 Pipeline Drugs for Hormonal Therapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Prostate Cancer Medicine Market Perspective (2016-2027)
2.2 Prostate Cancer Medicine Growth Trends by Regions
2.2.1 Prostate Cancer Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prostate Cancer Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Prostate Cancer Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Prostate Cancer Medicine Industry Dynamic
2.3.1 Prostate Cancer Medicine Market Trends
2.3.2 Prostate Cancer Medicine Market Drivers
2.3.3 Prostate Cancer Medicine Market Challenges
2.3.4 Prostate Cancer Medicine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Medicine Players by Revenue
3.1.1 Global Top Prostate Cancer Medicine Players by Revenue (2016-2021)
3.1.2 Global Prostate Cancer Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Medicine Revenue
3.4 Global Prostate Cancer Medicine Market Concentration Ratio
3.4.1 Global Prostate Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Medicine Revenue in 2020
3.5 Prostate Cancer Medicine Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Medicine Product Solution and Service
3.7 Date of Enter into Prostate Cancer Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Medicine Breakdown Data by Type
4.1 Global Prostate Cancer Medicine Historic Market Size by Type (2016-2021)
4.2 Global Prostate Cancer Medicine Forecasted Market Size by Type (2022-2027)

5 Prostate Cancer Medicine Breakdown Data by Application
5.1 Global Prostate Cancer Medicine Historic Market Size by Application (2016-2021)
5.2 Global Prostate Cancer Medicine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Prostate Cancer Medicine Market Size (2016-2027)
6.2 North America Prostate Cancer Medicine Market Size by Type
6.2.1 North America Prostate Cancer Medicine Market Size by Type (2016-2021)
6.2.2 North America Prostate Cancer Medicine Market Size by Type (2022-2027)
6.2.3 North America Prostate Cancer Medicine Market Size by Type (2016-2027)
6.3 North America Prostate Cancer Medicine Market Size by Application
6.3.1 North America Prostate Cancer Medicine Market Size by Application (2016-2021)
6.3.2 North America Prostate Cancer Medicine Market Size by Application (2022-2027)
6.3.3 North America Prostate Cancer Medicine Market Size by Application (2016-2027)
6.4 North America Prostate Cancer Medicine Market Size by Country
6.4.1 North America Prostate Cancer Medicine Market Size by Country (2016-2021)
6.4.2 North America Prostate Cancer Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Prostate Cancer Medicine Market Size (2016-2027)
7.2 Europe Prostate Cancer Medicine Market Size by Type
7.2.1 Europe Prostate Cancer Medicine Market Size by Type (2016-2021)
7.2.2 Europe Prostate Cancer Medicine Market Size by Type (2022-2027)
7.2.3 Europe Prostate Cancer Medicine Market Size by Type (2016-2027)
7.3 Europe Prostate Cancer Medicine Market Size by Application
7.3.1 Europe Prostate Cancer Medicine Market Size by Application (2016-2021)
7.3.2 Europe Prostate Cancer Medicine Market Size by Application (2022-2027)
7.3.3 Europe Prostate Cancer Medicine Market Size by Application (2016-2027)
7.4 Europe Prostate Cancer Medicine Market Size by Country
7.4.1 Europe Prostate Cancer Medicine Market Size by Country (2016-2021)
7.4.2 Europe Prostate Cancer Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Medicine Market Size (2016-2027)
8.2 Asia-Pacific Prostate Cancer Medicine Market Size by Type
8.2.1 Asia-Pacific Prostate Cancer Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prostate Cancer Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prostate Cancer Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Prostate Cancer Medicine Market Size by Application
8.3.1 Asia-Pacific Prostate Cancer Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prostate Cancer Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prostate Cancer Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Prostate Cancer Medicine Market Size by Region
8.4.1 Asia-Pacific Prostate Cancer Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prostate Cancer Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Prostate Cancer Medicine Market Size (2016-2027)
9.2 Latin America Prostate Cancer Medicine Market Size by Type
9.2.1 Latin America Prostate Cancer Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Prostate Cancer Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Prostate Cancer Medicine Market Size by Type (2016-2027)
9.3 Latin America Prostate Cancer Medicine Market Size by Application
9.3.1 Latin America Prostate Cancer Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Prostate Cancer Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Prostate Cancer Medicine Market Size by Application (2016-2027)
9.4 Latin America Prostate Cancer Medicine Market Size by Country
9.4.1 Latin America Prostate Cancer Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Prostate Cancer Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Medicine Market Size (2016-2027)
10.2 Middle East & Africa Prostate Cancer Medicine Market Size by Type
10.2.1 Middle East & Africa Prostate Cancer Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prostate Cancer Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prostate Cancer Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Prostate Cancer Medicine Market Size by Application
10.3.1 Middle East & Africa Prostate Cancer Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prostate Cancer Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prostate Cancer Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Prostate Cancer Medicine Market Size by Country
10.4.1 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca plc
11.1.1 AstraZeneca plc Company Details
11.1.2 AstraZeneca plc Business Overview
11.1.3 AstraZeneca plc Prostate Cancer Medicine Introduction
11.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2016-2021)
11.1.5 AstraZeneca plc Recent Development
11.2 Active Biotech
11.2.1 Active Biotech Company Details
11.2.2 Active Biotech Business Overview
11.2.3 Active Biotech Prostate Cancer Medicine Introduction
11.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2016-2021)
11.2.5 Active Biotech Recent Development
11.3 Bristol Myers-Squibb
11.3.1 Bristol Myers-Squibb Company Details
11.3.2 Bristol Myers-Squibb Business Overview
11.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Introduction
11.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2016-2021)
11.3.5 Bristol Myers-Squibb Recent Development
11.4 Teva Pharmaceuticals Industries Ltd.
11.4.1 Teva Pharmaceuticals Industries Ltd. Company Details
11.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview
11.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Introduction
11.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2016-2021)
11.4.5 Teva Pharmaceuticals Industries Ltd. Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Prostate Cancer Medicine Introduction
11.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer Inc.
11.6.1 Pfizer Inc. Company Details
11.6.2 Pfizer Inc. Business Overview
11.6.3 Pfizer Inc. Prostate Cancer Medicine Introduction
11.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2016-2021)
11.6.5 Pfizer Inc. Recent Development
11.7 Bayer AG
11.7.1 Bayer AG Company Details
11.7.2 Bayer AG Business Overview
11.7.3 Bayer AG Prostate Cancer Medicine Introduction
11.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2016-2021)
11.7.5 Bayer AG Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Prostate Cancer Medicine Introduction
11.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2016-2021)
11.8.5 Abbott Laboratories Recent Development
11.9 Astellas Pharma Inc.
11.9.1 Astellas Pharma Inc. Company Details
11.9.2 Astellas Pharma Inc. Business Overview
11.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Introduction
11.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2016-2021)
11.9.5 Astellas Pharma Inc. Recent Development
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Details
11.10.2 Roche Holding AG Business Overview
11.10.3 Roche Holding AG Prostate Cancer Medicine Introduction
11.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2016-2021)
11.10.5 Roche Holding AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Prostate Cancer Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of LHRH Antagonists
Table 3. Key Players of LHRH Analogs
Table 4. Key Players of Antiandrogens
Table 5. Key Players of Pipeline Drugs for Hormonal Therapy
Table 6. Global Prostate Cancer Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Prostate Cancer Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Prostate Cancer Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Prostate Cancer Medicine Market Share by Regions (2016-2021)
Table 10. Global Prostate Cancer Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Prostate Cancer Medicine Market Share by Regions (2022-2027)
Table 12. Prostate Cancer Medicine Market Trends
Table 13. Prostate Cancer Medicine Market Drivers
Table 14. Prostate Cancer Medicine Market Challenges
Table 15. Prostate Cancer Medicine Market Restraints
Table 16. Global Prostate Cancer Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Prostate Cancer Medicine Market Share by Players (2016-2021)
Table 18. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Medicine as of 2020)
Table 19. Ranking of Global Top Prostate Cancer Medicine Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prostate Cancer Medicine Product Solution and Service
Table 23. Date of Enter into Prostate Cancer Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Prostate Cancer Medicine Revenue Market Share by Type (2016-2021)
Table 27. Global Prostate Cancer Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Prostate Cancer Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Prostate Cancer Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Prostate Cancer Medicine Revenue Market Share by Application (2016-2021)
Table 31. Global Prostate Cancer Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Prostate Cancer Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Prostate Cancer Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Prostate Cancer Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Prostate Cancer Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Prostate Cancer Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Prostate Cancer Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Prostate Cancer Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Prostate Cancer Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Prostate Cancer Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Prostate Cancer Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Prostate Cancer Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 63. AstraZeneca plc Company Details
Table 64. AstraZeneca plc Business Overview
Table 65. AstraZeneca plc Prostate Cancer Medicine Product
Table 66. AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 67. AstraZeneca plc Recent Development
Table 68. Active Biotech Company Details
Table 69. Active Biotech Business Overview
Table 70. Active Biotech Prostate Cancer Medicine Product
Table 71. Active Biotech Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 72. Active Biotech Recent Development
Table 73. Bristol Myers-Squibb Company Details
Table 74. Bristol Myers-Squibb Business Overview
Table 75. Bristol Myers-Squibb Prostate Cancer Medicine Product
Table 76. Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 77. Bristol Myers-Squibb Recent Development
Table 78. Teva Pharmaceuticals Industries Ltd. Company Details
Table 79. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 80. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product
Table 81. Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 82. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 83. Johnson & Johnson Company Details
Table 84. Johnson & Johnson Business Overview
Table 85. Johnson & Johnson Prostate Cancer Medicine Product
Table 86. Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 87. Johnson & Johnson Recent Development
Table 88. Pfizer Inc. Company Details
Table 89. Pfizer Inc. Business Overview
Table 90. Pfizer Inc. Prostate Cancer Medicine Product
Table 91. Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 92. Pfizer Inc. Recent Development
Table 93. Bayer AG Company Details
Table 94. Bayer AG Business Overview
Table 95. Bayer AG Prostate Cancer Medicine Product
Table 96. Bayer AG Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 97. Bayer AG Recent Development
Table 98. Abbott Laboratories Company Details
Table 99. Abbott Laboratories Business Overview
Table 100. Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 101. Abbott Laboratories Recent Development
Table 102. Astellas Pharma Inc. Company Details
Table 103. Astellas Pharma Inc. Business Overview
Table 104. Astellas Pharma Inc. Prostate Cancer Medicine Product
Table 105. Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 106. Astellas Pharma Inc. Recent Development
Table 107. Roche Holding AG Company Details
Table 108. Roche Holding AG Business Overview
Table 109. Roche Holding AG Prostate Cancer Medicine Product
Table 110. Roche Holding AG Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 111. Roche Holding AG Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Medicine Market Share by Type: 2020 VS 2027
Figure 2. LHRH Antagonists Features
Figure 3. LHRH Analogs Features
Figure 4. Antiandrogens Features
Figure 5. Pipeline Drugs for Hormonal Therapy Features
Figure 6. Global Prostate Cancer Medicine Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Other Case Studies
Figure 9. Prostate Cancer Medicine Report Years Considered
Figure 10. Global Prostate Cancer Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Prostate Cancer Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Prostate Cancer Medicine Market Share by Regions: 2020 VS 2027
Figure 13. Global Prostate Cancer Medicine Market Share by Regions (2022-2027)
Figure 14. Global Prostate Cancer Medicine Market Share by Players in 2020
Figure 15. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Medicine as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Medicine Revenue in 2020
Figure 17. Global Prostate Cancer Medicine Revenue Market Share by Type (2016-2021)
Figure 18. Global Prostate Cancer Medicine Revenue Market Share by Type (2022-2027)
Figure 19. North America Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Prostate Cancer Medicine Market Share by Type (2016-2027)
Figure 21. North America Prostate Cancer Medicine Market Share by Application (2016-2027)
Figure 22. North America Prostate Cancer Medicine Market Share by Country (2016-2027)
Figure 23. United States Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Prostate Cancer Medicine Market Share by Type (2016-2027)
Figure 27. Europe Prostate Cancer Medicine Market Share by Application (2016-2027)
Figure 28. Europe Prostate Cancer Medicine Market Share by Country (2016-2027)
Figure 29. Germany Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Prostate Cancer Medicine Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Prostate Cancer Medicine Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Prostate Cancer Medicine Market Share by Region (2016-2027)
Figure 39. China Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Prostate Cancer Medicine Market Share by Type (2016-2027)
Figure 47. Latin America Prostate Cancer Medicine Market Share by Application (2016-2027)
Figure 48. Latin America Prostate Cancer Medicine Market Share by Country (2016-2027)
Figure 49. Mexico Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Prostate Cancer Medicine Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Prostate Cancer Medicine Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Prostate Cancer Medicine Market Share by Country (2016-2027)
Figure 55. Turkey Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AstraZeneca plc Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 59. Active Biotech Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 60. Bristol Myers-Squibb Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 61. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 63. Pfizer Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 64. Bayer AG Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 65. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 66. Astellas Pharma Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 67. Roche Holding AG Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[前立腺がん治療の世界市場規模・現状・予測2021年-2027年] (Global Prostate Cancer Medicine Market Size, Status and Forecast 2021-2027 / QY21JNE2772)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆